Part,  Chapter, Paragraph

 1    -,     1        |             Agencies (Appendix 3); and (v) considered by the Drafting
 2    -,     1        |           analysis; (iv) Risk factors; (v) Control tools and policies; (
 3   II,     5.  2.  6|                 Lekos D, Monti M, Puddu V, Taylor HL (1966). Epidemiological
 4   II,     5.  2.  7|         Allender S, Scarborough P, Peto V and Rayner M (2008): European
 5   II,     5.  2.  7|                 2008).~Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez
 6   II,     5.  2.  7|                E, Tuomilehto J, Salomaa V, Nissinn A (1998): Changes
 7   II,     5.  3.  2|                 of “Cancer Incidence in V Continents” and to produce
 8   II,     5.  4.  8|                 Mazovetsky A, Olchanski V., (1995) A computerized
 9   II,     5.  5.  1|            Gasquet I, Torres JV, Kovess V, Kessler RC, Alonso J and
10   II,     5.  5.  1|                 1730.~ ~Kovess-Masféty V, Alonso J, Brugha TS, Angermeyer
11   II,     5.  5.  3|            Samdal O, Barnekow Rasmussen V, eds. Available at: htt f (
12   II,     5.  5.  3|       Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC,
13   II,     5.  5.  3|                s15-s20.~Prince M, Patel V, Saxena S, Maj M, Maselko
14   II,     5.  5.  3|                412.~Endziniene M, Pauza V, Miseviciene V (1997): Prevalence
15   II,     5.  5.  3|                 M, Pauza V, Miseviciene V (1997): Prevalence of childhood
16   II,     5.  5.  3|                Vukusic S, Van Bockstael V, Gosselin S, Confavreux
17   II,     5.  5.  3|              allocates stages from I to V to indicate the relative
18   II,     5.  5.  3|               costs in HY stages IV and V has been reported, demonstrating
19   II,     5.  5.  3|    international studies (Schöffski and v.d. Schulenburg, 2007).~ ~
20   II,     5.  5.  3|           Kingdom WK, MacMahon DG, Peto V, Playfer JR (2003): Direct
21   II,     5.  5.  3|           Carreras M, Casetta I, Govoni V, Tola MR, Paolino E, Monetti
22   II,     5.  5.  3|                 502.~Nicoletti A, Sofia V, Bartoloni A, Bartalesi
23   II,     5.  5.  3|                 3):250-255~Schöffski O, v.d. Schulenburg J-M., 2007.
24   II,     5.  6.  6|            Nguyen M, Thiesce A, Listrat V, Jacob L, Nakache JP, Gabriel
25   II,     5.  6.  6|                111:87-98~Lock C, Allgar V, Jones K, Marples G, Chandler
26   II,     5.  7.  1|         dialysis)~585.5~585.6 (if ESRD)~V codes for dialysis or transplantation~
27   II,     5.  7.  7|                2005.~Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani
28   II,     5.  8.  7|                 BM, Petersen LJ, Backer V (2007): The prevalence of
29   II,     5.  8.  7|              773.~ ~Masa JF, Sobradillo V, Villasante C, Jimenez-Ruiz
30   II,     5.  9.  4|                Cladosporium herbarium; (v) Alternaria alternata; (
31   II,     5.  9.  4|                 of PM such as vanadium (V), nickel (Ni), zinc (Zn),
32   II,     5.  9.  4|      correlations were observed between V, Ni, and SO(4) and the allergen
33   II,     5. 10.  7|               Res 51, 135-147.~ ~Brusic V, Millot M, Petrovsky N,
34   II,     5. 11.  7|               126.~ ~Diepgen TL, Mahler V (2002): The epidemiology
35   II,     7.  5    |         evidence-based approaches; and (v) to participate in international
36   II,     8.  2.  1|                J. and Rutkowski-Kmitta, V. (2005). Disability Statistics
37   II,     8.  2.  1|            Borthwick-Duffy, S., Bradley,V., Buntinx, W.H.E., Coulter,
38   II,     8.  2.  3|                  Assennato G, Sallustio V (1996): Epidemiology of
39   II,     9.  1.  1|                 2002;103(1):4-13.~Apgar V (1953): A t. Curr. Res.
40   II,     9.  1.  2|                  Goujard J, Steinbicker V, Roesch C, McDonnell R,
41   II,     9.  1.  2|              Gatt M, McDonnell R, Nelen V and Stone D (2005c): "Survey
42   II,     9.  1.  2|                 Garne E, Loane M, Nelen V, Bakker M, Gener B, Abramsky
43   II,     9.  3.  1|                84(1): p. 50-56.~ ~Beral V (2003): Breast cancer and
44   II,     9.  3.  1|          Wilhelm K, Barclay L & Schmied V (2005): 'Big build': hidden
45   II,     9.  3.  1|              723-754.~ ~Qaseem, A Snow, V Shekelle, P Hopkins Jr R.
46   II,     9.  3.  2|          Marpeau L, Marchand L, Pierrat V, Larroque B, et al (2007):
47   II,     9.  3.  3|            Samdal O, Barnekow Rasmussen V (2004) Young people’s health
48   II,     9.  5.  6|                RoutledgeFalmer.~ ~Beral V 2003: Breast cancer and
49   II,     9.  5.  6|                Denton M, Prus S, Walter V (2004): Gender differences
50  III,    10.  1.  3|                Rev 19(5):513-530.~Burke V, Beilin LJ, Milligan R,
51  III,    10.  1.  3|           Solorzano R, Kelley M, Darrow V, Gendrop SC, Strickland
52  III,    10.  1.  3|                N, Armstrong T, Candeias V, Keller I, Riley L, Roy
53  III,    10.  2.  1|            mortality among drug users; (v) demand for drug treatment),
54  III,    10.  2.  1|            Samdal O, Barnekow Rasmussen V, eds (2004): Young people’
55  III,    10.  2.  1|           Gallus S, Colombo P, Scarpino V, Zuccaro P, Negri E, Apolone
56  III,    10.  2.  1|                 1174-1179.~ ~Grabauskas V, Klumbienė J, Petkevičienė
57  III,    10.  2.  1|                 Šakytė E, Kriaučionienė V, Paalanen L, Prättälä R (
58  III,    10.  2.  1|               Kapantais E, Haralambides V, Tzotzas T, Mortoglou A,
59  III,    10.  2.  1|                  Yeh MC, Nawaz H, Njike V, Anderson LM, Cory S, Dietz
60  III,    10.  2.  1|            Telesný vývoj detí a mládeže v Slovenskej republike [Physical
61  III,    10.  2.  1|                  Paccaud F, Wietlisbach V, Rickenbach M (2001): Body
62  III,    10.  2.  1|             Mourão I, Moreira P, Rosado V (2004): Prevalence of overweight
63  III,    10.  2.  1|        Grīnberga D, Villeruša A, Dzērve V, Zīle S, Helasoja V, Paalanen
64  III,    10.  2.  1|              Dzērve V, Zīle S, Helasoja V, Paalanen L, Prättälä R (
65  III,    10.  2.  1|                M, Lagiou P, Kalapothaki V, Evangelista A, Frasca G,
66  III,    10.  2.  1|                K, Lagiou P, Kalapothaki V, Masala G, Giurdanella MC,
67  III,    10.  2.  1|          Vasilopoulou E, Bellos G, Pala V, Masala G, Tumino R, Sacerdote
68  III,    10.  2.  1|             San-Jose B, Welch AA, Krogh V, Luben R, Allen N, Overvad
69  III,    10.  2.  1|           Klipstein-Grobusch K, Benetou V, Zavitsanos X, Tumino R,
70  III,    10.  2.  5|                 J, Ispanovic-Radojkovic V, Paradisiotou A, Tamminen
71  III,    10.  2.  5|                 J, Ispanovic-Radojkovic V, Rudic N, Tamminen T, Turunen
72  III,    10.  4.  2|                 wound infection~ ~High (V. vulnificus),~ ~ ~ ~Medium (
73  III,    10.  4.  2|       pesticides. Particularly, Chapter V (articles 26 through 34)
74  III,    10.  5.  1|                 15(1-2): 1-12.~Loftness V, Hakkinen B, Adan O, Nevalainen
75  III,    10.  6.  1|           Richter M, Morgan A, Barnekow V (Eds.). HBSC international
76   IV,    11.  6.  5|               1162.~ ~Goldfarb NI, Maio V et al. (2003): How Does
77   IV,    12. 10    |            Campaign: FA C T S A N D A D V I C E~about smoking and
78   IV,    12. 10    |            according to § 20 Abs. 1 SGB V (Social Code Book V, Prevention
79   IV,    12. 10    |                 SGB V (Social Code Book V, Prevention and health promotion),
80   IV,    12. 10    |                related.~§ 20 Abs. 1 SGB V (Social Code Book V, Prevention
81   IV,    12. 10    |                 SGB V (Social Code Book V, Prevention and health promotion):
82   IV,    12. 10    |                 interventions.~§ 21 SGB V (prevention of dental diseases):
83   IV,    12. 10    |             well (legal basis: § 43 SGB V and SGB IX).~National health
84   IV,    12. 10    |          programs according to § 20 SGB V (see above) and of different
85   IV,    12. 10    | health promotion. According to § 65 SGB V Statutory Sickness Funds
86   IV,    12. 10    |                 Intermediate~ ~§ 21 SGB V prevention of dental diseases:
87   IV,    12. 10    |               out by dentists,~§ 22 SGB V prevention of dental diseases:
88   IV,    12. 10    |            activities~ ~§ 20 Abs. 1 SGB V (Social Security Code V)
89   IV,    12. 10    |                 V (Social Security Code V) Prevention and Health Promotion
90   IV,    12. 10    |          employer’s duty(1996)~§20b SGB V; Act on prevention of work-related
91   IV,    12. 10    |     Hypertension~High priority25 SGB V Preventive Health examination (